Integrated BioPharma enters $4.5M PNC credit facility; replaces prior debt

INTEGRATED BIOPHARMA INC

New $4M revolving line of credit and $500K convertible equipment line from PNC Bank (SOFR+250bps).
Maturity date April 5, 2026; borrowed funds for working capital and equipment purchases.
Prior credit facility fully repaid and terminated; payoff amount was $7,864.51 on April 15, 2025.
Reimbursement agreement covers standby/commercial letters of credit up to $1M sublimit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.